New York Life Trust’s Leidos LDOS Stock Holding History

New York Life Trust’s Portfolio LDOS Stock Details LDOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-1,591	Closed	-$90K	–	267
2015 Q4	$90K	Buy	+1,591	New	+$83.9K	0.39%	104

Other funds holding LDOS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

New York Life Trust's LDOS Position: Q1 2016 in Review

New York Life Trust sold out of Leidos (LDOS) in Q1 2016, closing a stake of 1,591 shares — an estimated $90K sold.

New York Life Trust first reported a position in LDOS in Q4 2015 and held it in 1 quarter. The position peaked at $90K in Q4 2015. 267 funds tracked by Wall St. Rank hold LDOS as of Q1 2016.

New York Life Trust reported no remaining Leidos position as of Q1 2016 after selling out during the quarter.
New York Life Trust sold 1,591 Leidos shares in Q1 2016, an estimated $90K.
New York Life Trust first reported a position in Leidos in Q4 2015 and held it in 1 quarter.
New York Life Trust's Leidos position peaked at $90K in Q4 2015.
267 funds tracked by Wall St. Rank held Leidos as of Q1 2016.

Based on New York Life Trust's 13F filing for Q1 2016, filed 16 May 2016.